chevron_leftBack
As of 5 June 2026, BioLineRx Ltd. has a market cap of $10.91M USD, ranking #40831 globally and #540 in Israel.
It ranks #3628 in the Healthcare sector, and #1183 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$10.91MUSD
31.33M ILS
Enterprise Value
$4.69MUSD
13.55M ILS
Revenue (TTM)
$1.31MUSD
3.76M ILS
EBITDA (TTM)
-$11.09MUSD
-32.07M ILS
Net Income (TTM)
-$1.3MUSD
-3.75M ILS
Profit Margin
-100%
PS Ratio
8.3
PB Ratio
0.4
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Philip Serlin
open_in_new
Employees
24
Founded
2003
Website
biolinerx.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 8.3% | 0% | 0% | -13% | -38% | -32% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
BLRX
ביוליין אר אקס בע''מ
ISIN: IL0011015182
Shares Out.:
Shares Outstanding:
2.621B1
Shares Float:
2.508B2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1 ILA | |
|
NASDAQ
MIC: XNAS
|
BLRX
ביוליין אר אקס בע''מ ADR
ISIN: US09071M3043
Shares Out.:
Shares Outstanding:
4.368M1
Shares Float:
4.344M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
3.07 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About BioLineRx Ltd.
BioLineRx Ltd., a biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases. The company’s pipeline includes GLIX1, an oral, small molecule targeting DNA damage response in glioblastoma and other cancers; and APHEXDA (motixafortide), a peptide that is in Phase 1 clinical trial for the treatment of sickle cell disease, and Phase 2b clinical trial for the treatment of pancreatic cancer, as well as completed Phase 3 clinical trial for the treatment of multiple myeloma. It develops BL-5010, a pen-like applicator containing an acidic aqueous solution for the non-surgical removal of skin lesions. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Hevel Modi'in, Israel.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NASDAQ: SLGL
|
$231.51M
2K%
|
-
|
|
NASDAQ: MDWD
|
$209.11M
2K%
|
-
|
|
TLV: EPIT
|
$87.73M
704%
251.95M ILS
|
-
|
|
NASDAQ: PYPD
|
$86.83M
696%
|
-
|
|
NASDAQ: ENTX
|
$52.68M
383%
|
-
|
|
TLV: REKA
|
$46.66M
328%
134.01M ILS
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
7M%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
5M%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
3M%
|
97.4
|
|
SIX: RO
|
$323.4B
3M%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.25B
3M%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$276.26B
3M%
218.9B CHF
|
20.5
|
chevron_leftBack